Stay updated on MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial
Sign up to get notified when there's something new on the MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial page.

Latest updates to the MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPublications section now notes that entries are automatically filled from PubMed. The revision label has changed from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check20 days agoChange DetectedThe government funding status notice was removed from the page; no study details, eligibility criteria, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedPublications section updated: added Arbetter et al. 'Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo' (Clin Infect Dis, 2025; 81(3):634-644) and removed the ahead-of-print entry for 2024 (ciae596). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedCali, Colombia was added as a study location and Santiago de Cali, Colombia was removed. The Colombian site label now uses Cali.SummaryDifference0.3%

- Check56 days agoChange DetectedA new scholarly reference about RSV prevention in Chile has been added; there are no deletions or other content changes.SummaryDifference1%

- Check63 days agoChange DetectedCore content updated with a government funding status notice and a version bump to v3.2.0; previous v3.1.0 deletion indicates a standard version update.SummaryDifference2%

Stay in the know with updates to MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial page.